Latest filing published 01 Jun 2007 for INTROGEN THERAPEUTICS INC.
No signal scores available.
This profile gathers the share dealings of Charles E. Long in Introgen Therapeutics Inc. We count 2 filings; the first trade dates from 23 May 2006 and the latest from 30 May 2007.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 1 June 2007, the filings show a share grant in Introgen Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations